What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS Dividend Yield %?
MEDITERA TIBBI MALZEMENAYI VE TICARET ASIST:MEDTR -3.20%79 Dividend Yield % is 0.86% as of Jun. 27, 2026, which is 71% below its 10-year median of 2.93. GuruFocus rates IST:MEDTR with a GF Score™ of 79/100 and a GF Value™ of ₺43.43 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 328 Medical Devices & Instruments companies, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks worse than 79.27% on this metric.
IST:MEDTR's Dividend Yield % is ranked worse than 79.27% of 328
companies
in the Medical Devices & Instruments industry
Industry Median: 2
vs IST:MEDTR: 0.86
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is 1.68, which seems too high.
During the past 12 months, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's average Dividends Per Share Growth Rate was -14.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -47.70% per year.
During the past 8 years, the highest 3-Year average Dividends Per Share Growth Rate of MEDITERA TIBBI MALZEMENAYI VE TICARET AS was -47.70% per year. The lowest was -47.70% per year. And the median was -47.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Dividend Yield % Chart
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data
IST:MEDTR vs ABT, SYK, MDT: Dividend Yield % Comparison
For the Medical Devices subindustry, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Dividend Yield % falls into.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TRY 0.084034
2025-12-31
2026-01-02
2026-01-05
Cash Dividend
quarterly
TRY:TRY 1.000000
TRY 0.084034
2025-10-27
2025-10-30
2025-10-31
Cash Dividend
quarterly
TRY:TRY 1.000000
TRY 0.084034
2025-07-28
2025-07-29
2025-07-30
Cash Dividend
quarterly
TRY:TRY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) has a Dividend Yield % of 0.86% as of Jun. 27, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. This is 71% below median its historical median of 2.93. Over the past decade, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Dividend Yield % has ranged from 0.52 to 9.71. According to the industry distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #260 out of 328 companies in the Medical Devices & Instruments industry, placing it in the top 79.3%.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Dividend Yield % too high?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Dividend Yield % of 0.86% is 71% below median its 10-year median of 2.93. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 9.71. The Medical Devices & Instruments industry median Dividend Yield % is 2.00. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's value of 0.86% is 57% below this industry median. Based on the distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #260 out of 328 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, MEDITERA TIBBI MALZEMENAYI VE TICARET AS has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #260 out of 328 companies for Dividend Yield %. This places MEDITERA TIBBI MALZEMENAYI VE TICARET AS in the lower half of its industry. The industry median Dividend Yield % is 2.00. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's value of 0.86% is 57% below this benchmark. Historically, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's own Dividend Yield % has ranged from 0.52 to 9.71 over the past decade. While the company's 10-year median is 2.93 vs. the industry median of 2.00, MEDITERA TIBBI MALZEMENAYI VE TICARET AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 2.00, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Dividend Yield % of 0.86% is 57% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Dividend Yield % is 0.86%, which is 71% below median its own 10-year median of 2.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock overvalued right now?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₺43.43, compared to a current price of ₺28.44 — trading 34.5% below its estimated fair value. The current Dividend Yield % is 0.86%, which is 71% below median its 10-year median of 2.93 and 57% below the Medical Devices & Instruments industry median of 2.00. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR), the current Dividend Yield % is 0.86% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Overvalued in 2026?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock appears to be undervalued.
The current stock price of ₺28.44 is trading 34.5% below its estimated GF Value™ of ₺43.43.
GuruFocus considers MEDITERA TIBBI MALZEMENAYI VE TICARET AS to be Significantly Undervalued.
Key valuation signals for IST:MEDTR:
Dividend Yield %: 0.86% (71% below median its 10-year median of 2.93)
GF Value™: ₺43.43 vs. price of ₺28.44 (34.5% below fair value)
Industry Position: 57% below the Medical Devices & Instruments median (#260 of 328)
No single metric tells the full story. See the IST:MEDTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.
79GF Score
Get the complete analysis for IST:MEDTR
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:MEDTR has been successfully added to your 
